Abstract
The need to identify and characterize vulnerable atherosclerotic lesions in humans has lead to the development of various animal models of plaque vulnerability. In this review, current concepts of the vulnerable plaque as it leads to an acute coronary event are described, such as plaque rupture, erosion, intraplaque hemorrhage and neovascularization. Recently developed animal models that have attempted to reproduce these concepts are described and evaluated based on their suitability in the study of vulnerable plaques. Although certain features of plaque vulnerability have been reported in animal models, a model encompassing all aspects of the vulnerable plaque is lacking.
Keywords: intravascular ultrasound, smooth muscle cell, matrix metalloproteinases, phagocytes, atherosclerosis
Current Pharmaceutical Design
Title: Animal Models to Study Plaque Vulnerability
Volume: 13 Issue: 10
Author(s): K. Schapira, S. Heeneman and M. J. A.P. Daemen
Affiliation:
Keywords: intravascular ultrasound, smooth muscle cell, matrix metalloproteinases, phagocytes, atherosclerosis
Abstract: The need to identify and characterize vulnerable atherosclerotic lesions in humans has lead to the development of various animal models of plaque vulnerability. In this review, current concepts of the vulnerable plaque as it leads to an acute coronary event are described, such as plaque rupture, erosion, intraplaque hemorrhage and neovascularization. Recently developed animal models that have attempted to reproduce these concepts are described and evaluated based on their suitability in the study of vulnerable plaques. Although certain features of plaque vulnerability have been reported in animal models, a model encompassing all aspects of the vulnerable plaque is lacking.
Export Options
About this article
Cite this article as:
Schapira K., Heeneman S. and A.P. Daemen J. M., Animal Models to Study Plaque Vulnerability, Current Pharmaceutical Design 2007; 13 (10) . https://dx.doi.org/10.2174/138161207780487575
DOI https://dx.doi.org/10.2174/138161207780487575 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Peptide and Non-peptide Antagonists Targeting Endothelin Receptors in Physiology and Pathology
Current Pharmaceutical Design Dyslipidaemia Related to Insulin Resistance and Cardiovascular Disease in South Asian and West African Populations
Current Pharmaceutical Design A Giant Internal Iliac Artery Aneurysm with Arteriovenous Fistulization
Current Medical Imaging Therapeutic Interventions in the Glyc(oxid)ation Pathway
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) MicroRNAs in Aortic Disease
Current Topics in Medicinal Chemistry Congenital Heart Disease in Non-Diabetic Large-for-Gestational-Age (LGA) Neonates
Cardiovascular & Hematological Disorders-Drug Targets Approaches and Recent Trends in Gene Delivery for Treatment of Atherosclerosis
Recent Patents on Drug Delivery & Formulation Novel Variants of DOCK8 Deficiency in a Case Series of Iranian Patients
Endocrine, Metabolic & Immune Disorders - Drug Targets Genetics of Atherosclerosis in Murine Models
Current Drug Targets Kawasaki Disease and Its Treatment – An Update
Current Rheumatology Reviews The Yin and Yang of BK Channels in Epilepsy
CNS & Neurological Disorders - Drug Targets Impact of Matrix Metalloproteinases on Atherosclerosis
Current Drug Targets Pathophysiology of IgG4-Related Disease
Current Immunology Reviews (Discontinued) Inflammation in Coronary Artery Disease and Acute Myocardial Infarction - is the Stage Set for Novel Therapies?
Current Pharmaceutical Design Role of Azoles in Cancer Prevention and Treatment: Present and Future Perspectives
Anti-Cancer Agents in Medicinal Chemistry Multifunctional RNase MCPIP1 and its Role in Cardiovascular Diseases
Current Medicinal Chemistry Hypertension - Current Natural Strategies to Lower Blood Pressure
Current Pharmaceutical Design Lost in Translation: What is Limiting Cardiomyoplasty and Can Tissue Engineering Help?
Current Stem Cell Research & Therapy Impact of Dysfunctional Protein Catabolism on Macrophage Cholesterol Handling
Current Medicinal Chemistry Interactions of Iron Oxide Nanoparticles with the Immune System: Challenges and Opportunities for their Use in Nano-oncology
Current Pharmaceutical Design